Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 42
2001 93
2002 129
2003 156
2004 115
2005 157
2006 135
2007 292
2008 215
2009 167
2010 147
2011 192
2012 228
2013 302
2014 347
2015 281
2016 297
2017 249
2018 197
2019 181
2020 144
Text availability
Article attribute
Article type
Publication date

Search Results

3,197 results
Results by year
Filters applied: . Clear all
Page 1
Phase 3 drug pipelines in the treatment of non-alcoholic steatohepatitis.
Sumida Y, Okanoue T, Nakajima A; Japan Study Group of NAFLD (JSG-NAFLD). Sumida Y, et al. Hepatol Res. 2019 Nov;49(11):1256-1262. doi: 10.1111/hepr.13425. Epub 2019 Oct 25. Hepatol Res. 2019. PMID: 31495973
Secondary sclerosing cholangitis with hemobilia induced by pembrolizumab: Case report and review of published work.
Koya Y, Shibata M, Shinohara N, Nebuya S, Oe S, Honma Y, Senju M, Sato N, Harada M. Koya Y, et al. Hepatol Res. 2019 Aug;49(8):950-956. doi: 10.1111/hepr.13329. Epub 2019 Apr 10. Hepatol Res. 2019. PMID: 30861263
[No authors listed] [No authors listed] Hepatol Res. 2019 Sep;49(9):1088. doi: 10.1111/hepr.13413. Hepatol Res. 2019. PMID: 31580001 No abstract available.
Emerging novel treatments for autoimmune liver diseases.
Tanaka A. Tanaka A. Hepatol Res. 2019 May;49(5):489-499. doi: 10.1111/hepr.13347. Epub 2019 May 1. Hepatol Res. 2019. PMID: 30969002 Review.
Emerging role of exosomes in liver physiology and pathology.
Cai S, Cheng X, Pan X, Li J. Cai S, et al. Hepatol Res. 2017 Feb;47(2):194-203. doi: 10.1111/hepr.12794. Epub 2016 Sep 29. Hepatol Res. 2017. PMID: 27539153 Review.
Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies.
Parohan M, Yaghoubi S, Seraji A. Parohan M, et al. Hepatol Res. 2020 Aug;50(8):924-935. doi: 10.1111/hepr.13510. Epub 2020 Jun 25. Hepatol Res. 2020. PMID: 32386449 Free PMC article. Review.
Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.
Nagaoki Y, Aikata H, Daijyo K, Teraoka Y, Shinohara F, Nakamura Y, Hatooka M, Morio K, Nakahara T, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Nagaoki Y, et al. Hepatol Res. 2018 Jan;48(1):51-58. doi: 10.1111/hepr.12895. Epub 2017 Apr 27. Hepatol Res. 2018. PMID: 28342265
Functional glycomics: Application to medical science and hepatology.
Miyoshi E, Kamada Y, Suzuki T. Miyoshi E, et al. Hepatol Res. 2020 Feb;50(2):153-164. doi: 10.1111/hepr.13459. Epub 2019 Dec 13. Hepatol Res. 2020. PMID: 31750967 Review.
The stratification of cirrhosis.
Maurice J, Pinzani M. Maurice J, et al. Hepatol Res. 2020 May;50(5):535-541. doi: 10.1111/hepr.13493. Epub 2020 Mar 5. Hepatol Res. 2020. PMID: 32072721 Review.
[No authors listed] [No authors listed] Hepatol Res. 2019 Aug;49(8):957. doi: 10.1111/hepr.13406. Epub 2019 Jul 25. Hepatol Res. 2019. PMID: 31464018 No abstract available.
3,197 results
Jump to page